During the past decade, Hospital Universitario Dr Jose Eleuterio Gonzalez conducted 171 clinical trials. In the 10-year time frame, 171 clinical trials started and 84 clinical trials were completed, i.e. on average, 49.1% percent of trials that started reached the finish line to date. In the past 5 years, 98 clinical trials started and 62 clinical trials were completed. i.e. 63.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Dr Jose Eleuterio Gonzalez" #1 sponsor was "Hospital Universitario Dr. Jose E. Gonzalez" with 38 trials, followed by "Eli Lilly and Company" with 36 trials sponsored, "Hoffmann-La Roche" with 23 trials sponsored, "Pfizer" with 19 trials sponsored and "Boehringer Ingelheim" with 19 trials sponsored. Other sponsors include 90 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Dr Jose Eleuterio Gonzalez" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator and "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Dr Jose Eleuterio Gonzalez" are "Rheumatoid Arthritis" (7 trials), "COVID-19" (6 trials), "Type 2 Diabetes" (6 trials), "Diabetes Mellitus, Type 2" (5 trials) and "Multiple Myeloma" (4 trials). Many other conditions were trialed in "Hospital Universitario Dr Jose Eleuterio Gonzalez" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Dr Jose Eleuterio Gonzalez" are "Drug" (185 trials), "Biological" (17 trials), "Other" (17 trials), "Device" (8 trials) and "Diagnostic Test" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (75 trials), "Baricitinib" (9 trials), "Tirzepatide" (9 trials), "Cyclophosphamide" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Dr Jose Eleuterio Gonzalez" are 199 trials for "All" genders, 21 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Dr Jose Eleuterio Gonzalez". 1 are not yet recruiting, 47 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 114 completed trials in Hospital Universitario Dr Jose Eleuterio Gonzalez, undefined suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Dr Jose Eleuterio Gonzalez, 12 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 18 trials that are defined as “Not Applicable".